Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Agios Pharm
AGIOCurrent price
45.38 USD
+0.07 USD (+0.15%)
Last closed
45.66 USD
Company
www.agios.com
ISIN
US00847X1046
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 588 636 160 USD
Yield for 12 month
+116.51 %
1Y
3Y
5Y
10Y
15Y
AGIO
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. Address: 88 Sidney Street, Cambridge, MA, United States, 02139
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
54.71 USDP/E ratio
–Dividend Yield
–Current Year
+26 823 000 USD
Last Year
+14 240 000 USD
Current Quarter
+8 615 000 USD
Last Quarter
+8 189 000 USD
Current Year
+17 319 000 USD
Last Year
+12 536 000 USD
Current Quarter
+5 527 000 USD
Last Quarter
+6 214 000 USD
Key Figures AGIO
1 year
3 years
5 years
10 years
EBITDA
-399 096 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-27.25 %
PEG Ratio
–
Return On Equity TTM
-44.92 %
Wall Street Target Price
54.71 USD
Revenue TTM
31 306 000 USD
Book Value
11.61 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
28.4 %
Dividend Yield
–
Gross Profit TTM
12 536 000 USD
Earnings per share
-6.5 USD
Diluted Eps TTM
-6.5 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics AGIO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AGIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation AGIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
2.4655
Enterprise Value Revenue
66.5484
Price Sales TTM
82.6882
Enterprise Value EBITDA
-2.3282
Price Book MRQ
3.9191
Financials AGIO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AGIO
For 52 weeks
19.8 USD
53.29 USD
50 Day MA
44.58 USD
Shares Short Prior Month
2 976 882
200 Day MA
36.78 USD
Short Ratio
6.09
Shares Short
3 275 023
Short Percent
5.84 %
BeatStart